These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2309 related articles for article (PubMed ID: 26633628)

  • 21. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
    Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
    Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
    Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
    Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
    Maniar K; Moideen A; Bhattacharyya R; Banerjee D
    Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
    Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
    PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of metformin, saxagliptin and repaglinide on gut microbiota in high-fat diet/streptozocin-induced type 2 diabetic mice.
    Tang Y; Yan M; Fang Z; Jin S; Xu T
    BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients.
    Niu X; Wang Y; Huang L; Guo P; Zhang S; Sun Y; Jin M
    Front Endocrinol (Lausanne); 2024; 15():1397034. PubMed ID: 39257903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota.
    Zheng J; Li H; Zhang X; Jiang M; Luo C; Lu Z; Xu Z; Shi J
    J Agric Food Chem; 2018 Jun; 66(23):5821-5831. PubMed ID: 29701959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
    Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
    Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
    Caesar R
    Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment.
    Ezzamouri B; Rosario D; Bidkhori G; Lee S; Uhlen M; Shoaie S
    NPJ Syst Biol Appl; 2023 Jan; 9(1):2. PubMed ID: 36681701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
    Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
    Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
    He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
    Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
    Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
    Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
    [No Abstract]   [Full Text] [Related]  

  • 35. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
    Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
    PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
    Zhang L; Luo J; Li X; Guo S; Shi D
    Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Region-Specific Effects of Metformin on Gut Microbiome and Metabolome in High-Fat Diet-Induced Type 2 Diabetes Mouse Model.
    Cheng M; Jia X; Ren L; Chen S; Wang W; Wang J; Cong B
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.
    Balvers M; Deschasaux M; van den Born BJ; Zwinderman K; Nieuwdorp M; Levin E
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome-Associated Gut Microbiome.
    Gradisteanu Pircalabioru G; Liaw J; Gundogdu O; Corcionivoschi N; Ilie I; Oprea L; Musat M; Chifiriuc MC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 116.